Primary superficial Ewing sarcoma: A unique entity? A case report including novel findings of ELF3 and TNFRSF14 copy number loss.

JOURNAL OF CUTANEOUS PATHOLOGY(2020)

Cited 4|Views22
No score
Abstract
Primary superficial Ewing sarcoma (psES) cases are exceedingly rare, with fewer than 150 cases reported in the literature. Small case series have suggested differences between psES and Ewing sarcoma (ES) of bone or deep soft tissues: psES appears to have a more indolent course and a higher 5-year overall survival rate. PsES is more common in older adolescent females as opposed to younger males in their peak growth velocity years in bone or deep soft tissue ES. We present a case report of a 17-year-old female with a relatively static nodule on her left thigh for 4 years. Morphologic, immunohistochemical, and molecular evaluations confirmed ES. Patient underwent a gross-total resection and a shortened course of adjuvant chemotherapy without radiation. Cancer gene panel testing found three gene abnormalities (in addition toEWSR1-FLI1fusion):CCND1copy number gain,ELF3copy number loss, andTNFRSF14copy number loss. To our knowledge, this is the first published case report of psES to include genomic sequencing and the first to reportELF3andTNFRSF14abnormalities in ES. Larger series of psES cases with genomic profiling are needed to elucidate a possible genetic etiology for its more indolent clinical course and favorable outcomes.
More
Translated text
Key words
CCND1,cutaneous Ewing sarcoma,ELF3,pediatric sarcoma,superficial Ewing sarcoma,TNFRSF14
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined